{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:31:29Z","timestamp":1785803489708,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08114-0","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:05:41Z","timestamp":1777107941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["METTL3-mediated m6A modification of lncRNA MALAT1 promotes colorectal cancer progression by activating the NF-\u03baB signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuangming","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6509-9123","authenticated-orcid":false,"given":"Dongbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"8114_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2011.173","volume":"8","author":"VV Lao","year":"2011","unstructured":"Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8:686\u2013700. https:\/\/doi.org\/10.1038\/nrgastro.2011.173.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8114_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol Cancer"},{"key":"8114_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Target Ther"},{"key":"8114_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12:121. https:\/\/doi.org\/10.1186\/s13045-019-0805-7.","journal-title":"J Hematol Oncol"},{"key":"8114_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19:88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"key":"8114_CR6","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.2174\/0929867330666230123144602","volume":"30","author":"X Qiu","year":"2023","unstructured":"Qiu X, Chen J. LSINCT5: A Novel lncRNA in Cancers. Curr Med Chem. 2023;30:4409\u201320. https:\/\/doi.org\/10.2174\/0929867330666230123144602.","journal-title":"Curr Med Chem"},{"key":"8114_CR7","doi-asserted-by":"publisher","unstructured":"Kazimierczyk M, Wrzesinski J, Long Non-Coding RNA, Epigenetics. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22116166.","DOI":"10.3390\/ijms22116166"},{"key":"8114_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/15476286.2016.1172756","volume":"14","author":"S Jain","year":"2017","unstructured":"Jain S, Thakkar N, Chhatai J, Pal Bhadra M, Bhadra U. Long non-coding RNA: Functional agent for disease traits. RNA Biol. 2017;14:522\u201335. https:\/\/doi.org\/10.1080\/15476286.2016.1172756.","journal-title":"RNA Biol"},{"key":"8114_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/ebc20200032","volume":"65","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65:625\u201339. https:\/\/doi.org\/10.1042\/ebc20200032.","journal-title":"Essays Biochem"},{"key":"8114_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50:1705\u201315. https:\/\/doi.org\/10.1038\/s41588-018-0252-3.","journal-title":"Nat Genet"},{"key":"8114_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/cbdd.14006","volume":"101","author":"F Malakoti","year":"2023","unstructured":"Malakoti F, Targhazeh N, Karimzadeh H, Mohammadi E, Asadi M, Asemi Z, et al. Multiple function of lncRNA MALAT1 in cancer occurrence and progression. Chem Biol Drug Des. 2023;101:1113\u201337. https:\/\/doi.org\/10.1111\/cbdd.14006.","journal-title":"Chem Biol Drug Des"},{"key":"8114_CR12","doi-asserted-by":"publisher","unstructured":"Wang X, Liu C, Zhang S, Yan H, Zhang L, Jiang A, et al. N(6)-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev Cell. 2021;56. https:\/\/doi.org\/10.1016\/j.devcel.2021.01.015.: 702\u2009\u2013\u200915.e8.","DOI":"10.1016\/j.devcel.2021.01.015"},{"key":"8114_CR13","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1007\/s12033-023-00953-2","volume":"66","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu Y, Qiu G, Luo Y, Bao Y, Lu J, et al. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells. Mol Biotechnol. 2024;66:3538\u201348. https:\/\/doi.org\/10.1007\/s12033-023-00953-2.","journal-title":"Mol Biotechnol"},{"key":"8114_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367. https:\/\/doi.org\/10.1038\/s41577-021-00534-x.","journal-title":"Nat Rev Immunol"},{"key":"8114_CR15","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"Q Sui","year":"2022","unstructured":"Sui Q, Zhang X, Chen C, Tang J, Yu J, Li W, et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat Commun. 2022;13:7316. https:\/\/doi.org\/10.1038\/s41467-022-35096-6.","journal-title":"Nat Commun"},{"key":"8114_CR16","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3748\/wjg.v25.i23.2863","volume":"25","author":"ZH Yang","year":"2019","unstructured":"Yang ZH, Dang YQ, Ji G. Role of epigenetics in transformation of inflammation into colorectal cancer. World J Gastroenterol. 2019;25:2863\u201377. https:\/\/doi.org\/10.3748\/wjg.v25.i23.2863.","journal-title":"World J Gastroenterol"},{"key":"8114_CR17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s44321-024-00066-6","volume":"16","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsche E, Hamai A, et al. CBX3 antagonizes IFNgamma\/STAT1\/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO Mol Med. 2024;16:1404\u201326. https:\/\/doi.org\/10.1038\/s44321-024-00066-6.","journal-title":"EMBO Mol Med"},{"key":"8114_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/bjc.2017.260","volume":"117","author":"SS Yang","year":"2017","unstructured":"Yang SS, Li XM, Yang M, Ren XL, Hu JL, Zhu XH, et al. FMNL2 destabilises COMMD10 to activate NF-kappaB pathway in invasion and metastasis of colorectal cancer. Br J Cancer. 2017;117:1164\u201375. https:\/\/doi.org\/10.1038\/bjc.2017.260.","journal-title":"Br J Cancer"},{"key":"8114_CR19","doi-asserted-by":"publisher","unstructured":"Buhrmann C, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Evidence That Calebin A, a Component of Curcuma Longa Suppresses NF-B Mediated Proliferation, Invasion and Metastasis of Human Colorectal Cancer Induced by TNF-beta (Lymphotoxin). Nutrients. 2019;11. https:\/\/doi.org\/10.3390\/nu11122904.","DOI":"10.3390\/nu11122904"},{"key":"8114_CR20","doi-asserted-by":"publisher","first-page":"867516","DOI":"10.3389\/fimmu.2022.867516","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu F, Chen L, Fang C, Li S, Yuan S, et al. Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-kappaB\/NLRP3 Inflammasome Pathway. Front Immunol. 2022;13:867516. https:\/\/doi.org\/10.3389\/fimmu.2022.867516.","journal-title":"Front Immunol"},{"key":"8114_CR21","doi-asserted-by":"publisher","first-page":"e28165","DOI":"10.1016\/j.heliyon.2024.e28165","volume":"10","author":"Y Huang","year":"2024","unstructured":"Huang Y, Lv Y, Yang B, Zhang S, Bixia L, Zhang C, et al. Enhancing m(6)A modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer. Heliyon. 2024;10:e28165. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28165.","journal-title":"Heliyon"},{"key":"8114_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-021-01048-8","volume":"14","author":"D Jin","year":"2021","unstructured":"Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, et al. m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 2021;14:32. https:\/\/doi.org\/10.1186\/s13045-021-01048-8.","journal-title":"J Hematol Oncol"},{"key":"8114_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016;62:335\u201345. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.021.","journal-title":"Mol Cell"},{"key":"8114_CR24","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/ijc.24638","volume":"125","author":"E Bandres","year":"2009","unstructured":"Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 2009;125:2737\u201343. https:\/\/doi.org\/10.1002\/ijc.24638.","journal-title":"Int J Cancer"},{"key":"8114_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12935-024-03360-y","volume":"24","author":"RT Ma","year":"2024","unstructured":"Ma RT, Wang Y, Ji F, Chen JN, Wang TJ, Liu Y, et al. YTHDF1\u2019s grip on CRC vasculature: insights into LINC01106 and miR-449b-5p-VEGFA axis. Cancer Cell Int. 2024;24:195. https:\/\/doi.org\/10.1186\/s12935-024-03360-y.","journal-title":"Cancer Cell Int"},{"key":"8114_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016;63:306\u201317. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.041.","journal-title":"Mol Cell"},{"key":"8114_CR27","doi-asserted-by":"publisher","first-page":"114165","DOI":"10.1016\/j.celrep.2024.114165","volume":"43","author":"M Pomaville","year":"2024","unstructured":"Pomaville M, Chennakesavalu M, Wang P, Jiang Z, Sun HL, Ren P, et al. Small-molecule inhibition of the METTL3\/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation. Cell Rep. 2024;43:114165. https:\/\/doi.org\/10.1016\/j.celrep.2024.114165.","journal-title":"Cell Rep"},{"key":"8114_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/circulationaha.118.036146","volume":"139","author":"LE Dorn","year":"2019","unstructured":"Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M, et al. The N(6)-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy. Circulation. 2019;139:533\u201345. https:\/\/doi.org\/10.1161\/circulationaha.118.036146.","journal-title":"Circulation"},{"key":"8114_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41420-022-00880-2","volume":"8","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhao X, Wang J, Jin Y, Gong M, Ye Y, et al. METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing. Cell Death Discov. 2022;8:80. https:\/\/doi.org\/10.1038\/s41420-022-00880-2.","journal-title":"Cell Death Discov"},{"key":"8114_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12935-021-02113-5","volume":"21","author":"C Zhao","year":"2021","unstructured":"Zhao C, Ling X, Xia Y, Yan B, Guan Q. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1\/miR-26b\/HMGA2 axis. Cancer Cell Int. 2021;21:441. https:\/\/doi.org\/10.1186\/s12935-021-02113-5.","journal-title":"Cancer Cell Int"},{"key":"8114_CR31","doi-asserted-by":"publisher","first-page":"136094","DOI":"10.1016\/j.jhazmat.2024.136094","volume":"480","author":"T Xiao","year":"2024","unstructured":"Xiao T, Wang P, Wu M, Cheng C, Yang Y, Bian Q, et al. METTL3-regulated m6A modification of lncRNA E230001N04Rik is involved in myofibroblast differentiation in arsenic-induced pulmonary fibrosis through promoting senescence of lung epithelial cells. J Hazard Mater. 2024;480:136094. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.136094.","journal-title":"J Hazard Mater"},{"key":"8114_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevImmunol.2023050267","volume":"43","author":"T He","year":"2023","unstructured":"He T, Xia H, Chen B, Duan Z, Huang C. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer. Crit Rev Immunol. 2023;43:43\u201353. https:\/\/doi.org\/10.1615\/CritRevImmunol.2023050267.","journal-title":"Crit Rev Immunol"},{"key":"8114_CR33","doi-asserted-by":"publisher","first-page":"1476030","DOI":"10.3389\/fimmu.2024.1476030","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yi Y, Han C, Shi B. NF-kappaB signaling pathway in tumor microenvironment. Front Immunol. 2024;15:1476030. https:\/\/doi.org\/10.3389\/fimmu.2024.1476030.","journal-title":"Front Immunol"},{"key":"8114_CR34","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","volume":"31","author":"A Khan","year":"2024","unstructured":"Khan A, Zhang Y, Ma N, Shi J, Hou Y. NF-kappaB role on tumor proliferation, migration, invasion and immune escape. Cancer Gene Ther. 2024;31:1599\u2013610. https:\/\/doi.org\/10.1038\/s41417-024-00811-6.","journal-title":"Cancer Gene Ther"},{"key":"8114_CR35","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/jcp.30730","volume":"237","author":"W Zhao","year":"2022","unstructured":"Zhao W, Li J, Ma Q, Cai J, Li A, Wu W, et al. N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis. J Cell Physiol. 2022;237:2729\u201339. https:\/\/doi.org\/10.1002\/jcp.30730.","journal-title":"J Cell Physiol"},{"key":"8114_CR36","doi-asserted-by":"publisher","first-page":"107226","DOI":"10.1016\/j.jbc.2024.107226","volume":"300","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li Z, Peng Q, Liu C, Wu Y, Wen Y, et al. Epstein-Barr virus suppresses N(6)-methyladenosine modification of TLR9 to promote immune evasion. J Biol Chem. 2024;300:107226. https:\/\/doi.org\/10.1016\/j.jbc.2024.107226.","journal-title":"J Biol Chem"},{"key":"8114_CR37","doi-asserted-by":"publisher","unstructured":"Wang J, Yan S, Lu H, Wang S, Xu D. METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-kappaB Signaling Pathway. Mediators Inflamm. 2019;2019(3120391). https:\/\/doi.org\/10.1155\/2019\/3120391.","DOI":"10.1155\/2019\/3120391"},{"key":"8114_CR38","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.7150\/ijbs.58514","volume":"17","author":"J Wang","year":"2021","unstructured":"Wang J, Tan L, Jia B, Yu X, Yao R, N OU, et al. Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD\/NF-kappaB Pathway. Int J Biol Sci. 2021;17:2633\u201351. https:\/\/doi.org\/10.7150\/ijbs.58514.","journal-title":"Int J Biol Sci"},{"key":"8114_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10565-022-09751-z","volume":"39","author":"P Ruan","year":"2023","unstructured":"Ruan P, Wang S, Yang C, Huang X, Sun P, Tan A. m(6)A mRNA methylation regulates the ERK\/NF-kappaB\/AKT signaling pathway through the PAPPA\/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer. Cell Biol Toxicol. 2023;39:1611\u201326. https:\/\/doi.org\/10.1007\/s10565-022-09751-z.","journal-title":"Cell Biol Toxicol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08114-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:39:47Z","timestamp":1781138387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08114-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8114"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08114-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fujian Medical University Affiliated Longyan First Hospital (Approval No.: LYREC2024-k027-01). All procedures were conducted in accordance with the Declaration of Helsinki and national ethical guidelines for medical research. Written informed consent was obtained from all participants or their legal guardians prior to enrollment, ensuring voluntary participation and confidentiality of personal health information. The study design prioritized patient safety and privacy throughout the research process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Clinical study ethics approval and consent to participate"}},{"value":"All animal experiments were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by Gannan Innovation and Translational Medicine Research Institute (Approval No.: MI-20250051). All efforts were made to minimize animal suffering and to reduce the number of animals used in the experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Animal study ethical statement"}},{"value":"All authors have reviewed and approved the final version of this manuscript for publication. Written informed consent was obtained from all participants (or their legal guardians) for the publication of anonymized data derived from their clinical samples in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"756"}}